Advisory: Alerts on drug access wrongly tagged to Rubicon Organics withdrawn
11/12/2024 13:50
Alerts on telehealth company Ro providing access to single-dose
vials of Eli Lilly's LLY.N weight-loss drug Zepbound were
inadvertently tagged to Canada-based Rubicon Organics ROMJ.V ,
an unrelated company, and have been withdrawn.
For the correctly coded alert on Ro and Lilly, click
urn:newsml:reuters.com:*:nFWN3NC1E6
STORY_NUMBER: nTUA7DPQDY
STORY_DATE: 11/12/2024
STORY_TIME: 01:00:16 PM GMT
((bangalore.newsroom@thomsonreuters.com))
Recent news on Rubicon Organics
See all newsCanada's Rubicon Organics Q1 revenue rises, sees H2 adjusted EBITDA improvement
Advisory: Alert wrongly tagged to Rubicon Organics withdrawn
Advisory: Alert incorrectly tagged to Rubicon Organics withdrawn
Canada's Rubicon Organics Q4 revenue beats estimates on higher production
Brief: Rubicon Organics Q4 Revenue CAD 16.5 Million